Form Type: 4

SEC EDGAR Link
Accession Number:0001439222-21-000054
Date:2021-05-28
Issuer: AGIOS PHARMACEUTICALS, INC. (AGIO)
Original Submission Date:

Reporting Person:

MARAGANORE JOHN
C/O AGIOS PHARMACEUTICALS, INC.
88 SIDNEY STREET CAMBRIDGE, MA 02139

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-02-04 G 3,415 d $0.00 26,757 direct
COMMON STOCK 2021-05-28 M 1,686 a $0.00 28,443 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2021-05-28 deemed execution date M 1,686 (d) common stock 1,686 $0.00 0 direct
Footnotes
IDfootnote
f1 this disposition reflects a bona fide gift of 3,415 shares to charity.
f2 each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
f3 the restricted stock units were granted on may 28, 2020. the shares underlying the stock units will vest in full on may 28, 2021. vested shares will be delivered to the reporting person within three businessdays after such shares become vested.

Elevate your investments